ACARBOSE

ACARBOSE was reported 3936 times

ACARBOSE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MAST CELL DEGRANULATION PRESENT 7 0.3684
1 NEUROGLYCOPENIA 25 0.2273
2 EOSINOPHIL COUNT NORMAL 3 0.2143
3 PERIPHERAL ARTERY HAEMATOMA 6 0.2143
4 INTESTINAL TRANSIT TIME ABNORMAL 6 0.1091
5 HYPEROXALURIA 13 0.0756
6 PERIPHERAL CIRCULATORY FAILURE 24 0.0585
7 DIABETIC KETOSIS 13 0.0342
8 MULTIPLE DRUG THERAPY 21 0.0279
9 ACETONAEMIA 7 0.0278
10 PORTAL VENOUS GAS 9 0.0248
11 HYPOGLYCAEMIC COMA 69 0.0239
12 ALLERGY TO IMMUNOGLOBULIN THERAPY 2 0.0183
13 CARDIOSPASM 10 0.0179
14 INSULIN AUTOIMMUNE SYNDROME 6 0.0168
15 DIABETIC VASCULAR DISORDER 4 0.0161
16 POSTPRANDIAL HYPOGLYCAEMIA 3 0.0160
17 SUPINE HYPERTENSION 3 0.0159
18 CORONARY ARTERY REOCCLUSION 2 0.0152
19 HYPOCAPNIA 6 0.0144
20 SCROTAL INFECTION 3 0.0143
21 HYPEROSMOLAR STATE 4 0.0139
22 PALMOPLANTAR KERATODERMA 10 0.0138
23 HYPOGLYCAEMIC ENCEPHALOPATHY 5 0.0129
24 KETOSIS 13 0.0120
25 RETINITIS PIGMENTOSA 3 0.0115
26 GASTRIC POLYPS 25 0.0111
27 CONTRAST ENCEPHALOPATHY 3 0.0109
28 PNEUMATOSIS INTESTINALIS 31 0.0109
29 DIABETIC METABOLIC DECOMPENSATION 15 0.0108
30 BLOOD CHOLESTEROL DECREASED 20 0.0107
31 ALBUMIN URINE PRESENT 4 0.0105
32 ALCOHOLIC PANCREATITIS 2 0.0103
33 BRONCHIAL FISTULA 2 0.0099
34 ANTI-INSULIN ANTIBODY POSITIVE 2 0.0096
35 PSEUDOSTROKE 3 0.0087
36 STUPOR 25 0.0078
37 SKIN TURGOR DECREASED 3 0.0077
38 PSEUDOLYMPHOMA 4 0.0072
39 GLUCOSE URINE PRESENT 9 0.0071
40 RETICULOCYTE COUNT DECREASED 3 0.0070
41 HYPERLEUKOCYTOSIS 6 0.0068
42 RENAL CANCER METASTATIC 5 0.0065
43 BLOOD OSMOLARITY DECREASED 4 0.0064
44 URINE KETONE BODY PRESENT 10 0.0063
45 VANISHING BILE DUCT SYNDROME 7 0.0063
46 ATRIOVENTRICULAR BLOCK FIRST DEGREE 27 0.0062
47 DIABETES MELLITUS INADEQUATE CONTROL 110 0.0062
48 HYPERGAMMAGLOBULINAEMIA 3 0.0062
49 MONOPARESIS 11 0.0061
50 QUADRIPARESIS 10 0.0060
51 INCISION SITE PAIN 7 0.0060
52 HYPOGLYCAEMIA 287 0.0059
53 DIABETIC NEPHROPATHY 13 0.0059
54 HYPOPROTEINAEMIA 11 0.0058
55 LABELLED DRUG-DRUG INTERACTION ISSUE 8 0.0055
56 DYSLALIA 4 0.0055
57 PRESBYOPIA 3 0.0054
58 SKIN TEST POSITIVE 5 0.0054
59 MARASMUS 8 0.0053
60 ATRIAL TACHYCARDIA 11 0.0052
61 QRS AXIS ABNORMAL 4 0.0052
62 MUCOSAL DRYNESS 10 0.0050
63 BLOOD URIC ACID ABNORMAL 2 0.0049
64 ADRENAL MASS 4 0.0048
65 PRURITUS GENITAL 11 0.0047
66 HYPERMAGNESAEMIA 3 0.0046
67 GASTROINTESTINAL MUCOSAL DISORDER 3 0.0046
68 CHRONIC GASTRITIS 10 0.0044
69 CEREBRAL HYPOPERFUSION 2 0.0043
70 HYPOCHLORAEMIA 5 0.0043
71 BRADYKINESIA 25 0.0042
72 CYTOLYTIC HEPATITIS 14 0.0042
73 LACUNAR INFARCTION 10 0.0042
74 CELL DEATH 8 0.0040
75 BLOOD CREATINE INCREASED 17 0.0038
76 EUGLYCAEMIC DIABETIC KETOACIDOSIS 15 0.0036
77 PEPTIC ULCER 12 0.0036
78 KETOACIDOSIS 27 0.0036
79 LACTIC ACIDOSIS 112 0.0035
80 AORTIC CALCIFICATION 2 0.0034
81 PANCREATITIS CHRONIC 8 0.0034
82 MUSCLE NECROSIS 3 0.0033
83 DIABETIC RETINOPATHY 11 0.0032
84 MICTURITION DISORDER 11 0.0032
85 SEDATION COMPLICATION 8 0.0031
86 RED BLOOD CELLS URINE POSITIVE 3 0.0031
87 ALLERGIC OEDEMA 2 0.0031
88 ANION GAP INCREASED 4 0.0030
89 HYPERLACTACIDAEMIA 8 0.0030
90 TOXIC ENCEPHALOPATHY 15 0.0030
91 CAROTID ARTERIOSCLEROSIS 3 0.0029
92 PARKINSONISM 28 0.0029
93 VASCULAR PURPURA 4 0.0029
94 HYPOPERFUSION 3 0.0029
95 BLOOD LACTIC ACID INCREASED 15 0.0028
96 BRONCHIAL WALL THICKENING 2 0.0028
97 CEREBRAL INFARCTION 68 0.0028
98 AMNIOTIC CAVITY INFECTION 2 0.0028
99 DIABETIC COMPLICATION 7 0.0027
100 PNEUMOPERITONEUM 5 0.0027
101 BLOOD GLUCOSE ABNORMAL 49 0.0027
102 AUTOIMMUNE THYROIDITIS 10 0.0026
103 DIABETIC NEUROPATHY 13 0.0026
104 SLEEP TERROR 11 0.0026
105 DAYDREAMING 4 0.0026
106 EPIDIDYMITIS 3 0.0026
107 TENSION HEADACHE 11 0.0026
108 COLITIS MICROSCOPIC 12 0.0025
109 HYPOTONIA 25 0.0025
110 CARDIAC DISCOMFORT 5 0.0025
111 CAROTID ARTERY OCCLUSION 9 0.0025
112 SKULL FRACTURE 4 0.0025
113 VASCULAR STENT THROMBOSIS 5 0.0025
114 DIABETIC KETOACIDOSIS 59 0.0025
115 BALANOPOSTHITIS 2 0.0024
116 BRADYARRHYTHMIA 4 0.0024
117 MELAENA 53 0.0024
118 AMAUROSIS 2 0.0024
119 MOTOR DYSFUNCTION 24 0.0024
120 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 3 0.0023
121 HYPERKALAEMIA 82 0.0023
122 PAPILLARY THYROID CANCER 4 0.0023
123 DIABETIC FOOT 7 0.0023
124 BLOOD TRIGLYCERIDES ABNORMAL 2 0.0023
125 BLOOD ALBUMIN INCREASED 2 0.0022
126 INITIAL INSOMNIA 23 0.0022
127 BLOOD PRESSURE SYSTOLIC DECREASED 10 0.0022
128 MUSCLE RIGIDITY 26 0.0022
129 PERIPHERAL ARTERY OCCLUSION 3 0.0021
130 PSYCHOMOTOR RETARDATION 6 0.0021
131 BLOOD UREA ABNORMAL 2 0.0021
132 BLOOD IMMUNOGLOBULIN E INCREASED 5 0.0021
133 APLASIA PURE RED CELL 7 0.0020
134 CARDIAC ANEURYSM 2 0.0020
135 HIATUS HERNIA 26 0.0020
136 CEREBRAL ATROPHY 8 0.0020
137 BRAIN HYPOXIA 2 0.0020
138 RETINAL ARTERY OCCLUSION 5 0.0020
139 HAEMODYNAMIC INSTABILITY 15 0.0020
140 BRAIN STEM INFARCTION 2 0.0020
141 QUADRIPLEGIA 4 0.0019
142 ELECTROCARDIOGRAM T WAVE ABNORMAL 3 0.0019
143 BLOOD GLUCOSE FLUCTUATION 21 0.0019
144 GASTROINTESTINAL STOMA COMPLICATION 3 0.0019
145 ASTERIXIS 2 0.0019
146 ANGINA UNSTABLE 12 0.0018
147 LEUKOCYTOCLASTIC VASCULITIS 3 0.0018
148 HYPERGLYCAEMIA 67 0.0018
149 HEPATITIS CHOLESTATIC 11 0.0018
150 PROTEIN URINE PRESENT 9 0.0018
151 BLOOD UREA INCREASED 30 0.0018
152 MYOCARDIAL NECROSIS MARKER INCREASED 3 0.0018
153 ANURIA 15 0.0017
154 GASTRITIS EROSIVE 8 0.0017
155 BILIRUBIN CONJUGATED INCREASED 4 0.0017
156 TYPE I HYPERSENSITIVITY 6 0.0017
157 GASTROINTESTINAL OEDEMA 3 0.0017
158 ACUTE LUNG INJURY 2 0.0017
159 MIXED LIVER INJURY 5 0.0017
160 ISCHAEMIC CARDIOMYOPATHY 5 0.0016
161 MYOPATHY 14 0.0016
162 DIASTOLIC DYSFUNCTION 5 0.0016
163 SHOCK HAEMORRHAGIC 13 0.0016
164 HAEMORRHAGIC ANAEMIA 7 0.0016
165 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 2 0.0016
166 HYPOMAGNESAEMIA 22 0.0016
167 MECHANICAL VENTILATION 3 0.0016
168 POLYMYALGIA RHEUMATICA 5 0.0016
169 ACIDOSIS 12 0.0016
170 RETINAL HAEMORRHAGE 11 0.0015
171 BILIARY OBSTRUCTION 2 0.0015
172 HYPERTRIGLYCERIDAEMIA 9 0.0015
173 RENAL TUBULAR NECROSIS 15 0.0015
174 EXFOLIATIVE RASH 4 0.0015
175 POLYDIPSIA 6 0.0015
176 HYPOGLYCAEMIC UNCONSCIOUSNESS 3 0.0015
177 LIPIDS INCREASED 3 0.0015
178 HYPOCALCAEMIA 28 0.0015
179 CENTRAL NERVOUS SYSTEM LYMPHOMA 2 0.0015
180 VITREOUS HAEMORRHAGE 4 0.0014
181 CAROTID ARTERY STENOSIS 5 0.0014
182 HYPERLIPIDAEMIA 17 0.0014
183 STAPHYLOCOCCAL SEPSIS 7 0.0014
184 CORONARY ARTERY STENOSIS 7 0.0014
185 PYODERMA GANGRENOSUM 5 0.0014
186 DYSLIPIDAEMIA 7 0.0014
187 SKIN WARM 8 0.0014
188 HENOCH-SCHONLEIN PURPURA 3 0.0014
189 ENDOMETRIAL CANCER 3 0.0014
190 BILIARY DILATATION 2 0.0014
191 BENIGN PROSTATIC HYPERPLASIA 7 0.0014
192 CHOLANGIOCARCINOMA 2 0.0013
193 RENAL FAILURE ACUTE 57 0.0013
194 PANCREATITIS ACUTE 30 0.0013
195 DIVERTICULUM INTESTINAL HAEMORRHAGIC 3 0.0013
196 METABOLIC ENCEPHALOPATHY 4 0.0013
197 THYROIDITIS 4 0.0013
198 NORMOCHROMIC NORMOCYTIC ANAEMIA 4 0.0013
199 PEMPHIGOID 10 0.0013
200 REBOUND ACID HYPERSECRETION 4 0.0013
201 GLYCOSYLATED HAEMOGLOBIN INCREASED 33 0.0013
202 RECTAL CANCER 4 0.0013
203 NEUROLOGICAL DECOMPENSATION 3 0.0013
204 COAGULATION TIME PROLONGED 2 0.0013
205 SUBARACHNOID HAEMORRHAGE 13 0.0013
206 ORTHOSTATIC HYPOTENSION 22 0.0013
207 ANTICHOLINERGIC SYNDROME 2 0.0013
208 BLOOD POTASSIUM INCREASED 20 0.0012
209 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 5 0.0012
210 CORONARY ARTERY DISEASE 37 0.0012
211 METABOLIC ACIDOSIS 39 0.0012
212 HYPERURICAEMIA 5 0.0012
213 ARTERIOSCLEROSIS CORONARY ARTERY 8 0.0012
214 ELECTROLYTE IMBALANCE 14 0.0012
215 CARDIAC FAILURE ACUTE 8 0.0012
216 SEDATION 31 0.0012
217 CEREBELLAR INFARCTION 2 0.0012
218 HEPATIC CYST 4 0.0012
219 AORTIC VALVE INCOMPETENCE 5 0.0012
220 PROTHROMBIN TIME PROLONGED 7 0.0012
221 BLOOD PH DECREASED 2 0.0012
222 AORTIC ARTERIOSCLEROSIS 3 0.0012
223 WOUND COMPLICATION 4 0.0012
224 ALTERED STATE OF CONSCIOUSNESS 25 0.0012
225 POSTMENOPAUSAL HAEMORRHAGE 3 0.0011
226 LUNG OPACITY 3 0.0011
227 DRUG ERUPTION 20 0.0011
228 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 3 0.0011
229 VITAMIN D DEFICIENCY 11 0.0011
230 FACIAL PAIN 10 0.0011
231 CARDIOGENIC SHOCK 16 0.0011
232 BLOOD GLUCOSE INCREASED 210 0.0011
233 DYSURIA 41 0.0011
234 BLOOD SODIUM INCREASED 3 0.0011
235 BEHAVIOUR DISORDER 6 0.0011
236 DRUG-INDUCED LIVER INJURY 34 0.0011
237 ARTERIOSCLEROSIS 10 0.0011
238 BLOOD GLUCOSE DECREASED 51 0.0011
239 URINARY RETENTION 35 0.0010
240 CONJUNCTIVAL HAEMORRHAGE 4 0.0010
241 CARCINOEMBRYONIC ANTIGEN INCREASED 2 0.0010
242 GASTROINTESTINAL NECROSIS 3 0.0010
243 AUTONOMIC NERVOUS SYSTEM IMBALANCE 3 0.0010
244 HYPONATRAEMIA 57 0.0010
245 HEPATITIS FULMINANT 3 0.0010
246 TRICUSPID VALVE INCOMPETENCE 8 0.0010
247 ANORECTAL DISORDER 2 0.0010
248 MUSCLE HAEMORRHAGE 4 0.0010
249 DYSCHEZIA 3 0.0010
250 LARYNGEAL OEDEMA 6 0.0010
251 CEREBRAL ISCHAEMIA 5 0.0010
252 SPINAL STENOSIS 4 0.0010
253 DRUG LEVEL INCREASED 16 0.0010
254 HEPATIC FUNCTION ABNORMAL 36 0.0010
255 PULSELESS ELECTRICAL ACTIVITY 4 0.0010
256 HYPOKALAEMIA 44 0.0010
257 ELECTROENCEPHALOGRAM ABNORMAL 3 0.0009
258 SERUM FERRITIN INCREASED 5 0.0009
259 HYPERPYREXIA 4 0.0009
260 HEMIPARESIS 16 0.0009
261 VASCULITIS 11 0.0009
262 ACUTE KIDNEY INJURY 144 0.0009
263 LUNG NEOPLASM 4 0.0009
264 DRUG INTERACTION 147 0.0009
265 HEPATIC LESION 4 0.0009
266 HEPATIC NEOPLASM 3 0.0009
267 LIPASE INCREASED 7 0.0009
268 INTESTINAL ISCHAEMIA 5 0.0009
269 GASTRIC ULCER HAEMORRHAGE 5 0.0009
270 NEPHRITIS 3 0.0009
271 ILEUS PARALYTIC 4 0.0009
272 CALCINOSIS 2 0.0009
273 CARDIOMEGALY 11 0.0009
274 MYOSITIS 8 0.0009
275 RHABDOMYOLYSIS 37 0.0009
276 INTERNATIONAL NORMALISED RATIO INCREASED 25 0.0009
277 ISCHAEMIA 4 0.0009
278 BLOOD CREATININE ABNORMAL 3 0.0009
279 BLOOD URIC ACID INCREASED 5 0.0009
280 POLYURIA 7 0.0009
281 RASH MACULO-PAPULAR 19 0.0009
282 VENTRICULAR TACHYCARDIA 14 0.0008
283 SINUS BRADYCARDIA 8 0.0008
284 LIVER TRANSPLANT 3 0.0008
285 CHRONIC KIDNEY DISEASE 62 0.0008
286 IMMUNE-MEDIATED ENTEROCOLITIS 3 0.0008
287 HYPOPHOSPHATAEMIA 6 0.0008
288 CEREBRAL DISORDER 6 0.0008
289 HEPATOTOXICITY 18 0.0008
290 GENERALISED OEDEMA 10 0.0008
291 MALNUTRITION 9 0.0008
292 GASTROINTESTINAL DISORDER 72 0.0008
293 HYPERNATRAEMIA 4 0.0008
294 BRAIN INJURY 8 0.0008
295 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 4 0.0008
296 DEMENTIA 22 0.0008
297 CARDIAC FAILURE 63 0.0008
298 UNRESPONSIVE TO STIMULI 20 0.0008
299 LIVER INJURY 19 0.0008
300 HEPATITIS ACUTE 5 0.0008
301 SUBDURAL HAEMATOMA 11 0.0008
302 BLOOD ALBUMIN DECREASED 6 0.0008
303 AZOTAEMIA 3 0.0008
304 BLOOD POTASSIUM ABNORMAL 2 0.0007
305 HAEMATEMESIS 19 0.0007
306 AREFLEXIA 2 0.0007
307 TRIGEMINAL NEURALGIA 3 0.0007
308 TYPE 2 DIABETES MELLITUS 25 0.0007
309 EOSINOPHILIA 13 0.0007
310 SHOCK 17 0.0007
311 COLD SWEAT 13 0.0007
312 LYMPHOCYTE COUNT DECREASED 13 0.0007
313 BLOOD CREATINE PHOSPHOKINASE INCREASED 21 0.0007
314 OSTEOPOROSIS 30 0.0007
315 TRANSAMINASES INCREASED 16 0.0007
316 BLOOD PRESSURE SYSTOLIC INCREASED 14 0.0007
317 ACUTE PULMONARY OEDEMA 4 0.0007
318 ANTIPSYCHOTIC DRUG LEVEL INCREASED 2 0.0007
319 LUNG INFECTION 11 0.0007
320 BUNDLE BRANCH BLOCK LEFT 3 0.0007
321 CEREBRAL THROMBOSIS 2 0.0007
322 CHOLECYSTITIS ACUTE 4 0.0007
323 POOR PERIPHERAL CIRCULATION 3 0.0007
324 CARDIAC FAILURE CHRONIC 3 0.0007
325 MYOCARDIAL ISCHAEMIA 8 0.0007
326 HEPATIC STEATOSIS 13 0.0007
327 MUSCLE TWITCHING 16 0.0007
328 OCULAR ICTERUS 3 0.0007
329 ANOSMIA 10 0.0007
330 BLOOD CREATININE INCREASED 45 0.0007
331 RALES 4 0.0007
332 PRODUCT PRESCRIBING ISSUE 15 0.0007
333 DIVERTICULUM INTESTINAL 3 0.0007
334 OEDEMA PERIPHERAL 83 0.0007
335 RENAL IMPAIRMENT 57 0.0007
336 BLOOD PRESSURE DECREASED 45 0.0007
337 ATAXIA 8 0.0007
338 VENTRICULAR EXTRASYSTOLES 7 0.0007
339 ISCHAEMIC STROKE 12 0.0007
340 CEREBROVASCULAR DISORDER 2 0.0007
341 BONE MARROW DISORDER 2 0.0007
342 CRANIOCEREBRAL INJURY 2 0.0007
343 BLOOD THYROID STIMULATING HORMONE DECREASED 3 0.0007
344 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 36 0.0007
345 EAR DISORDER 3 0.0007
346 PERICARDITIS 11 0.0007
347 RENAL FAILURE CHRONIC 5 0.0006
348 NEPHROGENIC ANAEMIA 3 0.0006
349 ACUTE MYOCARDIAL INFARCTION 19 0.0006
350 HAEMATURIA 22 0.0006
351 APPENDICITIS 6 0.0006
352 PLEURAL EFFUSION 39 0.0006
353 SUSPECTED SUICIDE 3 0.0006
354 RENAL CYST 5 0.0006
355 BLOOD TRIGLYCERIDES INCREASED 11 0.0006
356 ATELECTASIS 6 0.0006
357 BACTERIAL SEPSIS 2 0.0006
358 DECUBITUS ULCER 5 0.0006
359 PANCREATIC DISORDER 3 0.0006
360 PULMONARY CONGESTION 8 0.0006
361 CORONAVIRUS INFECTION 4 0.0006
362 INJECTION SITE INFLAMMATION 3 0.0006
363 HEMIPLEGIA 5 0.0006
364 ATRIAL FIBRILLATION 58 0.0006
365 HAEMODIALYSIS 5 0.0006
366 JAUNDICE 16 0.0006
367 TRANSIENT ISCHAEMIC ATTACK 20 0.0006
368 VULVOVAGINAL PRURITUS 3 0.0006
369 AGRANULOCYTOSIS 11 0.0006
370 SPEECH DISORDER 31 0.0006
371 SYNCOPE 59 0.0006
372 B-CELL LYMPHOMA 2 0.0006
373 CHOLECYSTITIS 7 0.0006
374 WEIGHT LOSS POOR 3 0.0006
375 GAMMA-GLUTAMYLTRANSFERASE INCREASED 13 0.0006
376 CORONARY ARTERY OCCLUSION 8 0.0006
377 CACHEXIA 3 0.0006
378 ONYCHOCLASIS 4 0.0006
379 RASH PAPULAR 13 0.0006
380 HAEMATOMA 15 0.0006
381 GASTRIC ULCER 11 0.0006
382 COGNITIVE DISORDER 27 0.0006
383 PERIORBITAL OEDEMA 3 0.0006
384 DIPLOPIA 15 0.0006
385 TONSILLITIS 3 0.0006
386 RIGHT VENTRICULAR FAILURE 4 0.0006
387 DUODENAL ULCER 4 0.0006
388 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 5 0.0006
389 PURPURA 5 0.0006
390 BODY HEIGHT DECREASED 6 0.0006
391 CONJUNCTIVAL HYPERAEMIA 2 0.0006
392 APPENDICECTOMY 2 0.0006
393 ANGINA PECTORIS 16 0.0006
394 MEDICATION ERROR 31 0.0006
395 DISTURBANCE IN ATTENTION 30 0.0006
396 GINGIVITIS 3 0.0006
397 ANAL INCONTINENCE 5 0.0006
398 ALANINE AMINOTRANSFERASE INCREASED 34 0.0006
399 GASTRIC DISORDER 19 0.0006
400 BLOOD PRESSURE ABNORMAL 11 0.0006
401 SEPTIC SHOCK 24 0.0006
402 CUTANEOUS VASCULITIS 2 0.0005
403 EXOSTOSIS 5 0.0005
404 FAECALOMA 3 0.0005
405 ASPARTATE AMINOTRANSFERASE INCREASED 29 0.0005
406 MOUTH HAEMORRHAGE 4 0.0005
407 INJECTION SITE NODULE 6 0.0005
408 RETINAL DETACHMENT 5 0.0005
409 ANGIOEDEMA 24 0.0005
410 BLINDNESS TRANSIENT 4 0.0005
411 VENTRICULAR FIBRILLATION 6 0.0005
412 BLINDNESS 22 0.0005
413 NECROSIS 3 0.0005
414 NEPHROPATHY 5 0.0005
415 FACE OEDEMA 9 0.0005
416 MITRAL VALVE INCOMPETENCE 6 0.0005
417 APHASIA 16 0.0005
418 SOPOR 7 0.0005
419 GRANULOCYTOPENIA 3 0.0005
420 HYPERTHERMIA 4 0.0005
421 C-REACTIVE PROTEIN INCREASED 19 0.0005
422 DISSOCIATION 4 0.0005
423 CARDIAC ARREST 43 0.0005
424 CHOLESTASIS 10 0.0005
425 BLOOD BILIRUBIN INCREASED 14 0.0005
426 EYELID OEDEMA 6 0.0005
427 CARDIOPULMONARY FAILURE 2 0.0005
428 NERVOUS SYSTEM DISORDER 16 0.0005
429 BRADYCARDIA 27 0.0005
430 HEPATOMEGALY 5 0.0005
431 PROSTATIC SPECIFIC ANTIGEN INCREASED 7 0.0005
432 BLOOD LACTATE DEHYDROGENASE INCREASED 8 0.0005
433 RENAL FAILURE 67 0.0005
434 OBESITY 8 0.0005
435 GENERAL PHYSICAL HEALTH DETERIORATION 58 0.0005
436 MOBILITY DECREASED 36 0.0005
437 DIABETES MELLITUS 38 0.0005
438 PNEUMOCYSTIS JIROVECII PNEUMONIA 5 0.0005
439 HEPATITIS B 3 0.0005
440 HEPATIC FAILURE 15 0.0005
441 TOXIC SKIN ERUPTION 5 0.0005
442 CYSTITIS HAEMORRHAGIC 2 0.0005
443 DEHYDRATION 66 0.0005
444 MUSCLE DISORDER 4 0.0005
445 ENCEPHALOPATHY 12 0.0005
446 NEUTROPHIL COUNT INCREASED 5 0.0005
447 HICCUPS 4 0.0005
448 ANAPHYLACTOID REACTION 2 0.0005
449 OLIGURIA 3 0.0005
450 RESPIRATORY FAILURE 35 0.0005
451 NEPHROLITHIASIS 22 0.0005
452 DERMATITIS ALLERGIC 6 0.0005
453 CARDIOMYOPATHY 7 0.0005
454 CARDIAC FAILURE CONGESTIVE 38 0.0005
455 CARDIOVASCULAR DISORDER 12 0.0005
456 URINARY INCONTINENCE 14 0.0005
457 EATING DISORDER 10 0.0005
458 EPISTAXIS 35 0.0005
459 GLAUCOMA 9 0.0005
460 HAEMOGLOBIN ABNORMAL 3 0.0005
461 METASTASES TO CENTRAL NERVOUS SYSTEM 6 0.0005
462 PRURITUS GENERALISED 10 0.0005
463 BRADYPHRENIA 3 0.0005
464 URINE OUTPUT DECREASED 4 0.0005
465 SPINAL OSTEOARTHRITIS 4 0.0005
466 INTESTINAL OBSTRUCTION 17 0.0005
467 RESPIRATORY RATE INCREASED 4 0.0005
468 NERVE INJURY 5 0.0004
469 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0004
470 PAIN OF SKIN 12 0.0004
471 WHITE BLOOD CELL COUNT INCREASED 17 0.0004
472 IMPAIRED GASTRIC EMPTYING 6 0.0004
473 RENAL INJURY 13 0.0004
474 ECCHYMOSIS 3 0.0004
475 PNEUMONIA BACTERIAL 4 0.0004
476 BUNDLE BRANCH BLOCK RIGHT 2 0.0004
477 UROSEPSIS 4 0.0004
478 LARGE INTESTINE POLYP 3 0.0004
479 BLOOD CHOLESTEROL ABNORMAL 2 0.0004
480 MENTAL STATUS CHANGES 12 0.0004
481 PULMONARY HYPERTENSION 9 0.0004
482 HUNGER 6 0.0004
483 DISORIENTATION 17 0.0004
484 ERYTHEMA MULTIFORME 4 0.0004
485 TACHYCARDIA 38 0.0004
486 CHOLELITHIASIS 14 0.0004
487 BLOOD SODIUM DECREASED 8 0.0004
488 THERMAL BURN 3 0.0004
489 FOOT FRACTURE 8 0.0004
490 PROTEINURIA 8 0.0004
491 LIP SWELLING 14 0.0004
492 COMA 20 0.0004
493 CATARACT 25 0.0004
494 NEUTROPHIL COUNT DECREASED 17 0.0004
495 ACCIDENTAL UNDERDOSE 6 0.0004
496 UPPER GASTROINTESTINAL HAEMORRHAGE 7 0.0004
497 HYPERTENSION 88 0.0004
498 HYPERCHOLESTEROLAEMIA 4 0.0004
499 TINNITUS 19 0.0004
500 ERUCTATION 8 0.0004
501 CONSTIPATION 90 0.0004
502 LIVER FUNCTION TEST ABNORMAL 12 0.0004
503 FAECES SOFT 3 0.0004
504 PALPITATIONS 48 0.0004
505 HYPOTHYROIDISM 13 0.0004
506 GLOMERULAR FILTRATION RATE DECREASED 5 0.0004
507 HAEMATOCRIT DECREASED 8 0.0004
508 BLADDER DISORDER 4 0.0004
509 PULMONARY MASS 6 0.0004
510 BLOOD ALKALINE PHOSPHATASE INCREASED 10 0.0004
511 ANEURYSM 2 0.0004
512 HYDRONEPHROSIS 3 0.0004
513 HYPOTHERMIA 4 0.0004
514 HYPOTENSION 79 0.0004
515 FALL 131 0.0004
516 MULTIPLE ORGAN DYSFUNCTION SYNDROME 11 0.0004
517 ANOREXIA 5 0.0004
518 TEMPERATURE INTOLERANCE 4 0.0004
519 LOW DENSITY LIPOPROTEIN INCREASED 3 0.0004
520 EYE PRURITUS 13 0.0004
521 LEUKOCYTOSIS 7 0.0004
522 HYPOALBUMINAEMIA 3 0.0004
523 END STAGE RENAL DISEASE 7 0.0004
524 PLATELET COUNT INCREASED 5 0.0004
525 ACCIDENTAL OVERDOSE 14 0.0004
526 GASTRITIS 10 0.0004
527 MOUTH ULCERATION 8 0.0004
528 PNEUMOTHORAX 6 0.0004
529 ASCITES 11 0.0004
530 MIOSIS 3 0.0004
531 MYASTHENIA GRAVIS 3 0.0004
532 HEART RATE DECREASED 13 0.0004
533 CHEILITIS 2 0.0004
534 RASH PRURITIC 20 0.0004
535 TACHYPNOEA 5 0.0004
536 ANAEMIA 70 0.0004
537 DECREASED APPETITE 85 0.0004
538 STAPHYLOCOCCAL INFECTION 12 0.0004
539 CEREBRAL HAEMORRHAGE 13 0.0004
540 ACUTE CORONARY SYNDROME 3 0.0004
541 EMBOLISM 3 0.0004
542 ARRHYTHMIA 17 0.0004
543 SENSATION OF FOREIGN BODY 3 0.0004
544 SEASONAL ALLERGY 5 0.0004
545 FLATULENCE 20 0.0004
546 CIRCULATORY COLLAPSE 6 0.0004
547 INTERSTITIAL LUNG DISEASE 17 0.0004
548 WEIGHT DECREASED 98 0.0004
549 VITAMIN D DECREASED 3 0.0004
550 SCAB 4 0.0004
551 CARDIAC VALVE DISEASE 2 0.0003
552 CARDIAC OPERATION 3 0.0003
553 DIZZINESS 174 0.0003
554 SKIN ULCER 9 0.0003
555 CORONARY ARTERY BYPASS 2 0.0003
556 INTENTIONAL SELF-INJURY 7 0.0003
557 PERICARDIAL EFFUSION 8 0.0003
558 SKIN SWELLING 3 0.0003
559 DEAFNESS 9 0.0003
560 PNEUMONIA 111 0.0003
561 GASTROENTERITIS 5 0.0003
562 CHEST DISCOMFORT 35 0.0003
563 SPINAL PAIN 4 0.0003
564 HYPOXIA 12 0.0003
565 VOMITING 160 0.0003
566 COVID-19 PNEUMONIA 4 0.0003
567 BACTERAEMIA 4 0.0003
568 HAEMOLYTIC ANAEMIA 3 0.0003
569 CARDIO-RESPIRATORY ARREST 14 0.0003
570 CHEST PAIN 62 0.0003
571 MUSCULAR WEAKNESS 38 0.0003
572 HYPERHIDROSIS 43 0.0003
573 MYELOSUPPRESSION 12 0.0003
574 BLOOD PRESSURE INADEQUATELY CONTROLLED 2 0.0003
575 OROPHARYNGEAL DISCOMFORT 3 0.0003
576 OEDEMA 18 0.0003
577 OSTEOMYELITIS 6 0.0003
578 LETHARGY 19 0.0003
579 ADRENAL INSUFFICIENCY 4 0.0003
580 TOXIC EPIDERMAL NECROLYSIS 5 0.0003
581 RESPIRATORY ARREST 9 0.0003
582 IRON DEFICIENCY ANAEMIA 3 0.0003
583 DEVICE RELATED INFECTION 5 0.0003
584 INJECTION SITE EXTRAVASATION 4 0.0003
585 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
586 GASTROINTESTINAL HAEMORRHAGE 27 0.0003
587 AMNESIA 21 0.0003
588 HAEMOPTYSIS 9 0.0003
589 CHOLANGITIS 2 0.0003
590 EJECTION FRACTION DECREASED 5 0.0003
591 BACTERIAL INFECTION 6 0.0003
592 ABDOMINAL PAIN UPPER 66 0.0003
593 DYSARTHRIA 12 0.0003
594 CELLULITIS 16 0.0003
595 FEBRILE NEUTROPENIA 21 0.0003
596 ASTHENIA 119 0.0003
597 ABDOMINAL DISTENSION 33 0.0003
598 HEAD INJURY 10 0.0003
599 MUSCLE ATROPHY 4 0.0003
600 HYPOPHAGIA 8 0.0003
601 PULMONARY OEDEMA 14 0.0003
602 ACUTE RESPIRATORY FAILURE 6 0.0003
603 DISCOMFORT 19 0.0003
604 ANAPHYLACTIC SHOCK 8 0.0003
605 INJECTION SITE INDURATION 4 0.0003
606 DEEP VEIN THROMBOSIS 20 0.0003
607 ORAL CANDIDIASIS 4 0.0003
608 TOXICITY TO VARIOUS AGENTS 51 0.0003
609 HAEMOGLOBIN DECREASED 31 0.0003
610 APPETITE DISORDER 2 0.0003
611 COAGULOPATHY 5 0.0003
612 EYE HAEMORRHAGE 4 0.0003
613 URINARY TRACT INFECTION 51 0.0003
614 CHOLECYSTITIS CHRONIC 2 0.0003
615 INJECTION SITE MASS 11 0.0003
616 EMPHYSEMA 3 0.0003
617 PRODUCT ADMINISTRATION ERROR 6 0.0003
618 SLUGGISHNESS 3 0.0003
619 HALLUCINATION 22 0.0003
620 BLOOD PRESSURE FLUCTUATION 7 0.0003
621 FEMUR FRACTURE 9 0.0003
622 HYPERBILIRUBINAEMIA 3 0.0003
623 MULTI-ORGAN FAILURE 5 0.0003
624 AUTOIMMUNE HEPATITIS 2 0.0003
625 PETECHIAE 3 0.0003
626 MASS 4 0.0003
627 GASTROOESOPHAGEAL REFLUX DISEASE 23 0.0003
628 SCRATCH 3 0.0003
629 DISSEMINATED INTRAVASCULAR COAGULATION 4 0.0003
630 SUDDEN DEATH 3 0.0003
631 ACUTE RESPIRATORY DISTRESS SYNDROME 5 0.0003
632 HEPATOCELLULAR INJURY 4 0.0003
633 DIALYSIS 4 0.0003
634 BLOOD PRESSURE INCREASED 43 0.0003
635 PYREXIA 97 0.0003
636 PNEUMONIA ASPIRATION 7 0.0003
637 PARALYSIS 4 0.0003
638 ABDOMINAL PAIN 65 0.0003
639 HYPOACUSIS 12 0.0003
640 DEPRESSED LEVEL OF CONSCIOUSNESS 11 0.0003
641 ELECTROCARDIOGRAM QT PROLONGED 10 0.0003
642 INCORRECT PRODUCT ADMINISTRATION DURATION 6 0.0003
643 HYPERTHYROIDISM 4 0.0003
644 PULMONARY ARTERIAL HYPERTENSION 4 0.0003
645 MYOCARDIAL INFARCTION 48 0.0003
646 OESOPHAGITIS 3 0.0003
647 NAUSEA 217 0.0003
648 HEART RATE INCREASED 27 0.0003
649 RED BLOOD CELL SEDIMENTATION RATE INCREASED 3 0.0003
650 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
651 RESPIRATORY TRACT INFECTION 7 0.0003
652 COLON CANCER 4 0.0003
653 IMMUNODEFICIENCY 4 0.0003
654 ABDOMINAL DISCOMFORT 45 0.0003
655 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
656 HEPATIC CIRRHOSIS 5 0.0003
657 BLOOD POTASSIUM DECREASED 8 0.0003
658 FRACTURE 5 0.0003
659 DYSPHAGIA 25 0.0003
660 CHOLECYSTECTOMY 3 0.0003
661 SLEEP APNOEA SYNDROME 5 0.0003
662 MYOCARDITIS 3 0.0003
663 POST PROCEDURAL COMPLICATION 5 0.0003
664 PRURITUS 100 0.0003
665 SEPSIS 29 0.0003
666 UPPER RESPIRATORY TRACT INFECTION 12 0.0003
667 VISUAL IMPAIRMENT 32 0.0003
668 BRONCHOPULMONARY ASPERGILLOSIS 2 0.0003
669 POST PROCEDURAL HAEMORRHAGE 3 0.0003
670 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
671 SKIN LESION 7 0.0003
672 KIDNEY INFECTION 5 0.0003
673 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
674 AFFECTIVE DISORDER 2 0.0003
675 CYANOSIS 4 0.0003
676 HAEMATOCHEZIA 14 0.0003
677 RASH ERYTHEMATOUS 12 0.0003
678 POLYNEUROPATHY 3 0.0003
679 DIARRHOEA 161 0.0002
680 ASPHYXIA 2 0.0002
681 CONVULSION 14 0.0002
682 ABNORMAL FAECES 2 0.0002
683 SMALL INTESTINAL OBSTRUCTION 3 0.0002
684 SPINAL OPERATION 3 0.0002
685 EYE DISORDER 8 0.0002
686 RIB FRACTURE 5 0.0002
687 LOSS OF CONSCIOUSNESS 31 0.0002
688 THROMBOCYTOPENIA 27 0.0002
689 VISUAL ACUITY REDUCED 8 0.0002
690 POLLAKIURIA 10 0.0002
691 SECRETION DISCHARGE 3 0.0002
692 DERMATITIS 5 0.0002
693 DRUG INTOLERANCE 23 0.0002
694 BLADDER CANCER 14 0.0002
695 CANDIDA INFECTION 4 0.0002
696 DRUG DOSE OMISSION 39 0.0002
697 INJECTION SITE IRRITATION 3 0.0002
698 INTRAOCULAR PRESSURE INCREASED 3 0.0002
699 PLATELET COUNT DECREASED 25 0.0002
700 HEPATITIS 6 0.0002
701 DRY MOUTH 19 0.0002
702 DRUG RESISTANCE 6 0.0002
703 CONTRAINDICATED PRODUCT ADMINISTERED 7 0.0002
704 STOMATITIS 14 0.0002
705 DELIRIUM 8 0.0002
706 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 12 0.0002
707 COMPLETED SUICIDE 19 0.0002
708 ANKYLOSING SPONDYLITIS 3 0.0002
709 ADVERSE REACTION 3 0.0002
710 LIVER DISORDER 10 0.0002
711 EAR INFECTION 6 0.0002
712 STEVENS-JOHNSON SYNDROME 5 0.0002
713 MALIGNANT MELANOMA 3 0.0002
714 THIRST 4 0.0002
715 CHROMATURIA 5 0.0002
716 TOOTHACHE 4 0.0002
717 PNEUMONITIS 6 0.0002
718 DRUG EFFECT INCOMPLETE 8 0.0002
719 DRUG TOXICITY 3 0.0002
720 HEPATIC ENZYME INCREASED 15 0.0002
721 LEUKOPENIA 11 0.0002
722 CYSTITIS 7 0.0002
723 DEPRESSION 50 0.0002
724 GINGIVAL BLEEDING 3 0.0002
725 WEIGHT INCREASED 49 0.0002
726 PERIPHERAL COLDNESS 3 0.0002
727 BRAIN NEOPLASM 2 0.0002
728 COORDINATION ABNORMAL 3 0.0002
729 VERTIGO 13 0.0002
730 OSTEOARTHRITIS 9 0.0002
731 SINUS TACHYCARDIA 3 0.0002
732 BLOOD URINE PRESENT 4 0.0002
733 DYSPNOEA 119 0.0002
734 RED BLOOD CELL COUNT DECREASED 6 0.0002
735 INCREASED APPETITE 4 0.0002
736 LOWER LIMB FRACTURE 4 0.0002
737 INFECTION 30 0.0002
738 HYPOAESTHESIA 31 0.0002
739 FLUID OVERLOAD 3 0.0002
740 EAR PAIN 4 0.0002
741 NEURALGIA 5 0.0002
742 AUTOIMMUNE DISORDER 2 0.0002
743 SKIN HAEMORRHAGE 3 0.0002
744 ABASIA 5 0.0002
745 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
746 PERIPHERAL SWELLING 31 0.0002
747 CEREBROVASCULAR ACCIDENT 34 0.0002
748 MYALGIA 34 0.0002
749 THROMBOSIS 16 0.0002
750 SUICIDE ATTEMPT 12 0.0002
751 FEEDING DISORDER 4 0.0002
752 VISION BLURRED 27 0.0002
753 MEMORY IMPAIRMENT 27 0.0002
754 INSURANCE ISSUE 3 0.0002
755 PHARYNGEAL OEDEMA 3 0.0002
756 ERECTILE DYSFUNCTION 5 0.0002
757 THYROID DISORDER 3 0.0002
758 LIMB DISCOMFORT 6 0.0002
759 ANKLE FRACTURE 3 0.0002
760 BACK PAIN 45 0.0002
761 RENAL DISORDER 9 0.0002
762 RASH GENERALISED 5 0.0002
763 CONFUSIONAL STATE 31 0.0002
764 MUCOSAL INFLAMMATION 5 0.0002
765 RESPIRATORY TRACT CONGESTION 3 0.0002
766 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
767 DYSPNOEA EXERTIONAL 7 0.0002
768 FREQUENT BOWEL MOVEMENTS 5 0.0002
769 COLITIS 7 0.0002
770 WHITE BLOOD CELL COUNT DECREASED 20 0.0002
771 LIMB INJURY 5 0.0002
772 BIPOLAR DISORDER 2 0.0002
773 PALLOR 5 0.0002
774 INTERVERTEBRAL DISC PROTRUSION 4 0.0002
775 IMPAIRED HEALING 6 0.0002
776 ASPIRATION 2 0.0002
777 FEELING COLD 5 0.0002
778 THERAPY NON-RESPONDER 8 0.0002
779 HEART RATE IRREGULAR 4 0.0002
780 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 3 0.0002
781 INJECTION SITE HAEMORRHAGE 14 0.0002
782 CONDITION AGGRAVATED 53 0.0002
783 HERPES ZOSTER 10 0.0002
784 INSOMNIA 46 0.0002
785 ECZEMA 9 0.0002
786 INTENTIONAL PRODUCT MISUSE 15 0.0002
787 COVID-19 30 0.0002
788 BLOOD IRON DECREASED 2 0.0002
789 MIGRAINE 16 0.0002
790 GASTROENTERITIS VIRAL 3 0.0002
791 OFF LABEL USE 145 0.0002
792 LACRIMATION INCREASED 5 0.0002
793 LOCALISED INFECTION 4 0.0002
794 MENTAL IMPAIRMENT 4 0.0002
795 RESTLESS LEGS SYNDROME 3 0.0002
796 PRODUCT USE ISSUE 31 0.0002
797 FIBROMYALGIA 4 0.0002
798 PRESYNCOPE 4 0.0002
799 UNDERDOSE 12 0.0002
800 DRUG ADMINISTRATION ERROR 5 0.0002
801 ANAPHYLACTIC REACTION 9 0.0002
802 OSTEONECROSIS OF JAW 4 0.0002
803 THINKING ABNORMAL 3 0.0002
804 BLISTER 9 0.0002
805 SWOLLEN TONGUE 5 0.0002
806 MALAISE 70 0.0002
807 GASTRIC CANCER 4 0.0002
808 PRODUCT USE IN UNAPPROVED INDICATION 39 0.0002
809 DRY SKIN 21 0.0002
810 SINUSITIS 16 0.0002
811 SEIZURE 18 0.0002
812 MOVEMENT DISORDER 5 0.0002
813 DRUG DEPENDENCE 25 0.0002
814 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 11 0.0002
815 HAEMORRHOIDS 3 0.0002
816 ORAL HERPES 3 0.0002
817 CHILLS 18 0.0002
818 PRODUCT DOSE OMISSION 10 0.0002
819 DISABILITY 3 0.0002
820 GAIT DISTURBANCE 29 0.0002
821 ARTHRALGIA 63 0.0002
822 UPPER LIMB FRACTURE 3 0.0002
823 FUNGAL INFECTION 5 0.0001
824 AGITATION 11 0.0001
825 SPINAL FRACTURE 3 0.0001
826 CARDIAC DISORDER 14 0.0001
827 INJECTION SITE PRURITUS 10 0.0001
828 SOMNOLENCE 30 0.0001
829 PRODUCT PHYSICAL ISSUE 3 0.0001
830 THROAT TIGHTNESS 4 0.0001
831 BONE MARROW FAILURE 3 0.0001
832 FLUSHING 15 0.0001
833 DISEASE RECURRENCE 7 0.0001
834 MUSCLE SPASMS 27 0.0001
835 PRODUCTIVE COUGH 7 0.0001
836 ACUTE HEPATIC FAILURE 2 0.0001
837 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
838 DEVICE ISSUE 13 0.0001
839 RESPIRATORY DISTRESS 4 0.0001
840 TREMOR 24 0.0001
841 INFLUENZA 16 0.0001
842 ROAD TRAFFIC ACCIDENT 6 0.0001
843 PAIN IN EXTREMITY 42 0.0001
844 OXYGEN SATURATION DECREASED 8 0.0001
845 BLINDNESS UNILATERAL 2 0.0001
846 ERYTHEMA 29 0.0001
847 INCORRECT DOSE ADMINISTERED 32 0.0001
848 RECTAL HAEMORRHAGE 6 0.0001
849 POOR QUALITY SLEEP 3 0.0001
850 FAECES DISCOLOURED 3 0.0001
851 FLUID RETENTION 7 0.0001
852 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
853 URTICARIA 23 0.0001
854 INJECTION SITE ERYTHEMA 17 0.0001
855 ANXIETY 39 0.0001
856 DYSSTASIA 4 0.0001
857 PULMONARY EMBOLISM 13 0.0001
858 RESTLESSNESS 5 0.0001
859 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
860 BRONCHITIS 10 0.0001
861 WHEEZING 8 0.0001
862 SNEEZING 3 0.0001
863 PANCREATITIS 7 0.0001
864 EMOTIONAL DISORDER 4 0.0001
865 EXPOSURE DURING PREGNANCY 8 0.0001
866 TREATMENT NONCOMPLIANCE 7 0.0001
867 BRAIN FOG 2 0.0001
868 ALOPECIA 25 0.0001
869 RASH 55 0.0001
870 NEUROPATHY PERIPHERAL 12 0.0001
871 PRODUCT PRESCRIBING ERROR 3 0.0001
872 ARTHROPATHY 7 0.0001
873 PRODUCT DOSE OMISSION ISSUE 37 0.0001
874 ABSCESS 2 0.0001
875 INTENTIONAL OVERDOSE 8 0.0001
876 HIP FRACTURE 4 0.0001
877 NIGHT SWEATS 4 0.0001
878 BACK DISORDER 2 0.0001
879 SWELLING FACE 8 0.0001
880 FATIGUE 95 0.0001
881 INFLUENZA LIKE ILLNESS 10 0.0001
882 AGEUSIA 3 0.0001
883 GAIT INABILITY 4 0.0001
884 BONE PAIN 7 0.0001
885 UNEVALUABLE EVENT 9 0.0001
886 HYPERSENSITIVITY 22 0.0001
887 PRODUCT QUALITY ISSUE 16 0.0001
888 COUGH 33 0.0001
889 SWELLING 11 0.0001
890 MALIGNANT NEOPLASM PROGRESSION 12 0.0001
891 INFLAMMATION 6 0.0001
892 PHARMACEUTICAL PRODUCT COMPLAINT 3 0.0001
893 THERAPEUTIC RESPONSE DECREASED 7 0.0001
894 DRUG INEFFECTIVE 151 0.0001
895 MUSCULOSKELETAL PAIN 6 0.0001
896 ARTHRITIS 9 0.0001
897 CONTUSION 11 0.0001
898 BURNING SENSATION 8 0.0001
899 NASOPHARYNGITIS 21 0.0001
900 HEADACHE 71 0.0001
901 LYMPHADENOPATHY 4 0.0001
902 DYSPEPSIA 11 0.0001
903 HOSPITALISATION 17 0.0001
904 BONE DISORDER 2 0.0001
905 PANIC ATTACK 4 0.0001
906 TREATMENT FAILURE 9 0.0001
907 RHINORRHOEA 7 0.0001
908 JOINT SWELLING 13 0.0001
909 PANCYTOPENIA 6 0.0001
910 NECK PAIN 6 0.0001
911 WOUND 3 0.0001
912 BLOOD CHOLESTEROL INCREASED 5 0.0001
913 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 5 0.0001
914 INCORRECT DRUG ADMINISTRATION DURATION 3 0.0001
915 ASTHMA 12 0.0001
916 PAIN 65 0.0001
917 OCULAR HYPERAEMIA 5 0.0001
918 NEOPLASM MALIGNANT 7 0.0001
919 HYPERSOMNIA 3 0.0001
920 INJECTION SITE SWELLING 8 0.0001
921 FEELING ABNORMAL 25 0.0001
922 BALANCE DISORDER 9 0.0001
923 INTENTIONAL PRODUCT USE ISSUE 9 0.0001
924 CHOKING 2 0.0001
925 COMPLICATION OF DEVICE INSERTION 2 0.0001
926 RESPIRATORY DISORDER 3 0.0001
927 INJECTION SITE BRUISING 8 0.0001
928 CYTOKINE RELEASE SYNDROME 2 0.0001
929 INJURY 7 0.0001
930 ILL-DEFINED DISORDER 6 0.0001
931 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 20 0.0001
932 PSORIATIC ARTHROPATHY 4 0.0001
933 BODY TEMPERATURE INCREASED 2 0.0001
934 INJECTION SITE RASH 3 0.0001
935 NEUTROPENIA 13 0.0001
936 PARAESTHESIA 15 0.0001
937 DYSGEUSIA 7 0.0001
938 DRUG EFFECT DECREASED 5 0.0001
939 DEVICE LEAKAGE 4 0.0001
940 PRODUCT STORAGE ERROR 8 0.0001
941 MUSCULOSKELETAL STIFFNESS 8 0.0001
942 EXPIRED PRODUCT ADMINISTERED 3 0.0001
943 VIRAL INFECTION 3 0.0001
944 ILLNESS 9 0.0001
945 NIGHTMARE 3 0.0001
946 NEOPLASM PROGRESSION 3 0.0001
947 RASH MACULAR 3 0.0001
948 MULTIPLE SCLEROSIS 4 0.0001
949 OVERDOSE 18 0.0001
950 LUNG DISORDER 4 0.0001
951 FEELING HOT 5 0.0001
952 INJECTION SITE PAIN 25 0.0001
953 DRY EYE 4 0.0001
954 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 14 0.0001
955 HAEMORRHAGE 8 0.0001
956 ANHEDONIA 2 0.0001
957 DISEASE PROGRESSION 9 0.0001
958 ABNORMAL BEHAVIOUR 3 0.0001
959 DEPRESSED MOOD 4 0.0001
960 OROPHARYNGEAL PAIN 7 0.0001
961 DYSKINESIA 3 0.0001
962 EYE PAIN 4 0.0001
963 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5 0.0001
964 EYE IRRITATION 4 0.0001
965 PRODUCT SUBSTITUTION ISSUE 4 0.0001
966 VAGINAL HAEMORRHAGE 3 0.0001
967 MENTAL DISORDER 3 0.0001
968 SURGERY 4 0.0001
969 ADVERSE DRUG REACTION 6 0.0001
970 SUICIDAL IDEATION 6 0.0001
971 BONE DENSITY DECREASED 2 0.0001
972 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
973 PROSTATE CANCER 5 0.0001
974 SKIN EXFOLIATION 5 0.0001
975 NERVOUSNESS 3 0.0001
976 SLEEP DISORDER 4 0.0001
977 MATERNAL EXPOSURE DURING PREGNANCY 5 0.0001
978 DEATH 47 0.0001
979 BREAST CANCER 5 0.0001
980 RHEUMATOID ARTHRITIS 6 0.0001
981 ABORTION SPONTANEOUS 2 0.0000
982 IRRITABILITY 3 0.0000
983 FOETAL EXPOSURE DURING PREGNANCY 4 0.0000
984 DRUG ABUSE 4 0.0000
985 INFUSION RELATED REACTION 3 0.0000
986 MULTIPLE SCLEROSIS RELAPSE 3 0.0000
987 ADVERSE EVENT 4 0.0000
988 DEVICE MALFUNCTION 3 0.0000
989 AGGRESSION 2 0.0000
990 HOT FLUSH 3 0.0000
991 ACNE 3 0.0000
992 PSORIASIS 5 0.0000
993 NO ADVERSE EVENT 6 0.0000
994 EMOTIONAL DISTRESS 4 0.0000